Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries

Expert Review of Molecular Diagnostics

Volumn 12, Issue 7, 2012, Pages 687-701

  Niemz, Angelika ^a   Boyle, David S ^b  

^a KECK GRADUATE INSTITUTE   (United States)

^b Program for Appropriate Technology in Health PATH   (United States)

Author keywords

CPA; diagnosis; integrated system; LAMP; Mycobacterium tuberculosis; near patient; nucleic acid amplification; pulmonary; sample preparation

Indexed keywords

DNA; ISONIAZID; NUCLEIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ARTICLE; BANGLADESH; BRAZIL; CAUSE OF DEATH; CHINA; CLINICAL EFFECTIVENESS; ETHIOPIA; HEALTH CARE COST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INDONESIA; ISOTHERM; LABORATORY DIAGNOSIS; LABORATORY TEST; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; NUCLEIC ACID AMPLIFICATION; PAKISTAN; PHILIPPINES; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREVALENCE; PROCESS DEVELOPMENT; QUALITY CONTROL; RUSSIAN FEDERATION; SOUTH AFRICA; TUBERCULOSIS; UNITED STATES;

DEVELOPING COUNTRIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; TUBERCULOSIS;

EID: 84869466671     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.71     Document Type: Article

References (68)

1. Harries AD, Dye C. Tuberculosis. Ann. Trop. Med. Parasitol. 100(5-6), 415-431 (2006). (Pubitemid 47050865)
2. Russell DG. Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5(1), 39-47 (2007). (Pubitemid 44942302)
3. Sacchettini JC, Rubin EJ, Freundlich JS. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol. 6(1), 41-52 (2008). (Pubitemid 350286219)
4. Zumla A, Abubakar I, Raviglione M et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J. Infect. Dis. 205(Suppl. 2), S228-S240 (2012).
5. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 10(2), 103-111 (2010).
6. Velayati AA, Masjedi MR, Farnia P et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136(2), 420-425 (2009).
7. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis. 196(Suppl. 1), S15-S27 (2007). (Pubitemid 47206081)
8. Uys PW, Warren R, van Helden PD, Murray M, Victor TC. Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent. J. Clin. Microbiol. 47(5), 1484-1490 (2009).
9. McNerney R, Daley P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat. Rev. Microbiol. 9(3), 204-213 (2011).
10. Somoskövi A, Ködmön C, Lantos A et al. Comparison of recoveries of Mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Löwenstein-Jensen medium. J. Clin. Microbiol. 38(6), 2395-2397 (2000). (Pubitemid 30414375)
11. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect. Dis. 12(3), 201-209 (2012).
12. Balasingham SV, Davidsen T, Szpinda I, Frye SA, Tønjum T Molecular diagnostics in tuberculosis: basis and implications for therapy. Mol. Diagn. Ther. 13(3), 137-151 (2009).
13. Boehme CC, Nabeta P, Hillemann D et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363(11), 1005-1015 (2010).
14. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177(7), 787-792 (2008). (Pubitemid 351490566)
15. Helb D, Jones M, Story E et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48(1), 229-237 (2010).
16. Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 6(9), 1067-1082 (2011).
17. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev. Mol. Diagn. 10(7), 937-946 (2010).
18. Mwaba P, McNerney R, Grobusch MP et al. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Trop. Med. Int. Health 16(7), 819-827 (2011).
19. Urdea M, Penny LA, Olmsted SS et al. Requirements for high impact diagnostics in the developing world. Nature 444(Suppl. 1), 73-79 (2006).
20. Weigl BH, Boyle DS, de los Santos T, Peck RB, Steele MS. Simplicity of use: a critical feature for widespread adoption of diagnostic technologies in low-resource settings. Expert Rev. Med. Devices 6(5), 461-464 (2009).
21. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng. 10, 107-144 (2008).
22. Ghanashyam B. Tuberculosis diagnostics: innovating to make an impact. Expert Rev. Anti. Infect. Ther. 9(4), 381-384 (2011).
23. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr. Opin. Pulm. Med. 16(3), 271-284 (2010).
24. Palamountain KM, Baker J, Cowan EP et al. Perspectives on introduction and implementation of new point-of-care diagnostic tests. J. Infect. Dis. 205(Suppl. 2), S181-S190 (2012).
25. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infect. 16(8), 1062-1069 (2010).
26. Schito M, Peter TF, Cavanaugh S et al. Opportunities and challenges for cost-effcient implementation of new point-of-care diagnostics for HIV and tuberculosis. J. Infect. Dis. 205(Suppl. 2), S169-S180 (2012).
27. Halse TA, Edwards J, Cunningham PL et al. Combined real-time PCR and rpoB gene pyrosequencing for rapid identifcation of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J. Clin. Microbiol. 48(4), 1182-1188 (2010).
28. Dalovisio JR, Montenegro-James S, Kemmerly SA et al. Comparison of the amplifed Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clin. Infect. Dis. 23(5), 1099-1106; discussion 1107 (1996). (Pubitemid 126782787)
29. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR. Recomm. Rep. 54(RR-17), 1-141 (2005).
30. Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr. Respir. Rev. 12(1), 16-21 (2011).
31. Green C, Huggett JF, Talbot E, Mwaba P, Reither K, Zumla AI. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplifcation methods. Lancet Infect. Dis. 9(8), 505-511 (2009).
32. Boehme CC, Nabeta P, Henostroza G et al. Operational feasibility of using loop-mediated isothermal amplifcation for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J. Clin. Microbiol. 45(6), 1936-1940 (2007). (Pubitemid 46933929)
33. Aldous WK, Pounder JI, Cloud JL, Woods GL. Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J. Clin. Microbiol. 43(5), 2471-2473 (2005). (Pubitemid 40656270)
34. Gomez DI, Mullin CS, Mora-Guzmán F et al. Rapid DNA extraction for specifc detection and quantitation of Mycobacterium tuberculosis DNA in sputum specimens using Taqman assays. Tuberculosis (Edinb.) 91(Suppl. 1), S43-S48 (2011).
35. Böddinghaus B, Wichelhaus TA, Brade V, Bittner T. Removal of PCR inhibitors by silica membranes: evaluating the Amplicor Mycobacterium tuberculosis kit. J. Clin. Microbiol. 39(10), 3750-3752 (2001). (Pubitemid 32954538)
36. Wilson S, Lane A, Rosedale R, Stanley C. Concentration of Mycobacterium tuberculosis from sputum using ligand-coated magnetic beads. Int. J. Tuberc. Lung Dis. 14(9), 1164-1168 (2010).
37. Mitarai S, Karinaga R, Yamada H et al. TRICORE, a novel bead-based specimen concentration method for the culturing of Mycobacterium tuberculosis. J. Microbiol. Methods 90(3), 152-155 (2012).
38. Vandeventer PE, Weigel KM, Salazar J et al. Mechanical disruption of lysis-resistant bacterial cells by use of a miniature, low-power, disposable device. J. Clin. Microbiol. 49(7), 2533-2539 (2011).
39. Belgrader P, Hansford D, Kovacs GT et al. A minisonicator to rapidly disrupt bacterial spores for DNA analysis. Anal. Chem. 71(19), 4232-4236 (1999). (Pubitemid 29466402)
40. Amaro A, Duarte E, Amado A, Ferronha H, Botelho A. Comparison of three DNA extraction methods for Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium subsp. avium. Lett. Appl. Microbiol. 47(1), 8-11 (2008). (Pubitemid 351839814)
41. Mori Y, Notomi T. Loop-mediated isothermal amplifcation (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J. Infect. Chemother. 15(2), 62-69 (2009).
42. Fang R, Li X, Hu L et al. Cross-priming amplifcation for rapid detection of Mycobacterium tuberculosis in sputum specimens. J. Clin. Microbiol. 47(3), 845-847 (2009).
43. Jeong YJ, Park K, Kim DE. Isothermal DNA amplifcation in vitro: the helicase-dependent amplifcation system. Cell. Mol Life Sci. 66(20), 3325-3336 (2009).
44. Torres-Chavolla E, Alocilja EC. Nanoparticle based DNA biosensor for tuberculosis detection using thermophilic Heli case-dependent isothermal amplifcation. Biosens. Bioelectron. 26(11), 4614-4618 (2011).
45. Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol. 4(7), e204 (2006).
46. Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 29(5), 240-250 (2011).
47. Dineva MA, Candotti D, Fletcher-Brown F, Allain JP, Lee H. Simultaneous visual detection of multiple viral amplicons by dipstick assay. J. Clin. Microbiol. 43(8), 4015-4021 (2005). (Pubitemid 41129694)
48. Goldmeyer J, Li H, McCormac M et al. Identifcation of Staphylococcus aureus and determination of methicillin resistance directly from positive blood cultures by isothermal amplifcation and a disposable detection device. J. Clin. Microbiol. 46(4), 1534-1536 (2008). (Pubitemid 351563611)
49. Raja S, Ching J, Xi L et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin. Chem. 51(5), 882-890 (2005). (Pubitemid 40577926)
50. Blakemore R, Story E, Helb D et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48(7), 2495-2501 (2010).
51. Boehme CC, Nicol MP, Nabeta P et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377(9776), 1495-1505 (2011).
52. Nicol MP, Workman L, Isaacs W et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect. Dis. 11(11), 819-824 (2011).
53. Mitarai S, Okumura M, Toyota E et al. Evaluation of a simple loop-mediated isothermal amplifcation test-kit for the diagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 15(9), 1211-1217, i (2011).
54. Poritz MA, Blaschke AJ, Byington CL et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS ONE 6(10), e26047 (2011).
55. Tanriverdi S, Chen L, Chen S. A rapid and automated sample-to-result HIV load test for near-patient application. J. Infect. Dis. 201(Suppl. 1), S52-S58 (2010).
56. Mahalanabis M, Do J, AlMuayad H, Zhang JY, Klapperich CM. An integrated disposable device for DNA extraction and Helicase-dependent amplifcation. Biomed. Microdevices 12(2), 353-359 (2010).
57. Wang CH, Lien KY, Wu JJ, Lee GB. A magnetic bead-based assay for the rapid detection of methicillin-resistant Staphylococcus aureus by using a microfuidic system with integrated loop-mediated isothermal amplifcation. Lab Chip 11(8), 1521-1531 (2011).
58. Wu Q, Jin W, Zhou C et al. Integrated glass microdevice for nucleic acid purifcation, loop-mediated isothermal amplifcation, and online detection. Anal. Chem. 83(9), 3336-3342 (2011).
59. Zwanziger R. Alere business overview presentation.Presented at: 30th Annual J.P. Morgan Healthcare Conference. San Fransisco, CA, USA, 11 January 2012.
60. Pai NP, Pai M. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov. Med. 13(68), 35-45 (2012).
61. Keeler E, Perkins MD, Small P et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444(Suppl. 1), 49-57 (2006).
62. Dowdy DW, O'Brien MA, Bishai D. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 12(9), 1021-1029 (2008).
63. Parsons LM, Somoskövi A, Gutierrez C et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin. Microbiol. Rev. 24(2), 314-350 (2011).
64. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8(4), 496-514 (1995).
65. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. PLoS Med. 6(2), e2 (2009).
66. Gershy-Damet GM, Rotz P, Cross D et al. The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region. Am. J. Clin. Pathol. 134(3), 393-400 (2010).
67. Engel N, Kenneth J, Pai M. TB diagnostics in India: creating an ecosystem for innovation. Expert Rev. Mol. Diagn. 12(1), 21-24 (2012).
68. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J. Acquir. Immune Defc. Syndr. 58 (2), 141-147 (2011).